Menu
🇧🇪
In 2018, in the innovative city of Ghent, an entrepreneurial journey unfolded – the incorporation of MyNEO, catalyzed by the vision of seasoned biotech pioneers Jan and Wim, alongside the ambition of Cedric, a driven graduated student. What commenced as an aspiration to build a novel bioinformatics platform swiftly evolved into a journey of exploration and innovation.
The founding team embarked on the development of a bioinformatics platform for personalized immunotherapies, assisting tier 1 pharma companies to navigate the intricacies of their own immunotherapeutic advancements. Their pursuit of innovation and the performance of their discovery engine unearthed a novel class of antigen targets found within the dark part of the genome – Camyotopes.
This pivotal discovery spurred a re-evaluation of the company’s purpose and mission. Transitioning from a service provider within the pharmaceutical sphere, MyNEO is now emerging as a force in the area of therapeutic development. Their research attained prominence in various medical journals, while their intellectual property portfolio is continuing to grow.
At the heart of their in-house development lies: Camyo-01, the most promising program. However, the Camyotopes discovery identified a whole array of molecules, for which the company is now in talks to out-license these development tracks and cultivate strategic alliances with Tier 1 pharmaceutical companies.
Next to that, the company has won many international prizes such as Most Disruptive Innovator, Forbes 30under30 and a spot in the Top 150 Digital Health Company Worldwide.
With the backing of TCD Capital, MyNEO is continuing their journey as a disruptor in the field of oncology.
News articles:
TCD Capital is a fund manager based in Brussels and Antwerp investing in Scale-Ups primarily in Smart Living, Tech, and Life Sciences.
Blijf op de hoogte van onze laatste activiteiten door u in te schrijven op onze nieuwsbrief.
Wij streven ernaar de inhoud aan te passen aan de segmenten die wij bedienen.
Dit zijn zowel fondsinvesteerders als de ondernemers met wie wij allianties hebben gesloten.
We houden graag contact.
